SELECT PUBLICATIONS
Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells. Keenen MM and Kim S. (2016) Breast Cancer (Dove Med Press) 8:211-221.
New and emerging factors in tumorigenesis: an overview. Kim S. (2015) Cancer Manag Res. 7:225-39.
Transient Induction of ING4 by Myc Drives Prostate Epithelial Cell Differentiation and Its Disruption Drives Prostate Tumorigenesis. Berger PL, Frank SB, Schulz VV, Nollet EA, Edick MJ, Holly B, Chang TT, Hostetter G, Kim S, Miranti CK. (2014) Cancer Res. 74(12):3357-68.
Attenuation of NF-kappa B by the ING4 tumor suppressor in breast cancer. Byron SA, Min E, Thal TS, Tapia C, Hostetter G, Watanabe A, Azorsa D, Little TH, and Kim S. (2012) PLoS One 7(10):e46823.
Deletion of the ING4 tumor suppressor gene is prevalent in HER2-positive breast cancer. Tapia C, Zlobec I, Schneider S, Kilic E, Guth U, Bubendorf L, and Kim S. (2011) Human Pathology 42(7): 983-90. PMID: 21315418